Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-372-6 | CAS number: 58-27-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin irritant, Cat. 2
Not classified for skin corrosion
Eye irritant, Cat. 2
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 22 August 2017 - 28 August 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- 28 July 2015
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
- Version / remarks:
- 20 July 2012
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- dd. 03 November 2015
- Specific details on test material used for the study:
- - No correction factor for purity required.
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Cell source:
- skin obtained from plastic surgery from multiple donors
- Justification for test system used:
- In the interest of sound science and animal welfare, a sequential testing strategy is recommended to minimise the need of in vivo testing. One of the validated in vitro skin irritation tests is the EPISKIN test, which is recommended in international guidelines (e.g. OECD and EC).
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- TEST SYSTEM
- EPISKIN Small Model (TM) (EPISKIN-SM (TM), 0.38 cm^2, Lot no.: 17-EKIN-034); a three-dimensional human epidermis model, which consists of adult human-derived epidermal keratinocytes which have been seeded in 12-well plates on a dermal substitute consisting of a collagen type I matrix coated with type IV collagen and cultured for 13 days.
SKIN DISC PREPARATION
- Procedure used: On the day of receipt the tissues were transferred to 12-well plates and preincubated with prewarmed Maintenance Medium for 21 hours at 37°C. No further preparation was applied.
ENVIRONMENTAL CONDITIONS
- Temperature used during treatment / exposure: room temperature
- Temperature of post-treatment incubation: 36.3-37.4 °C
- Humidity (%): 66-93
REMOVAL OF TEST MATERIAL AND CONTROLS
- Number of washing steps: 1, with phosphate buffered saline
- Observable damage in the tissue due to washing: no
MTT INTERACTION
Interaction with MTT was tested in a previous conducted skin corrosion test, it was concluded that the test item did not interfere with the MTT endpoint.
CONTROL TISSUES USED IN CASE OF MTT DIRECT INTERFERENCE
Although the test item did not interfere with MTT, three killed tissues treated with test item and three killed untreated tissues were used for the cytotoxicity valuation with MTT. In addition to the normal procedure, one tissue was treated with test item. Instead of MTT solution this tissue was incubated with assay medium.
- Procedure used to prepare the killed tissues: Living epidermis was transferred to 12 well plates and incubated with 2 ml Milli-Q for 48 ± 1 hours. After incubation, killed epidermis was stored at ≤ -15°C. Killed tissues were thawed by placing them for 1 hour at room temperature in 12 well plates on 2 ml maintenance medium. Further use of killed tissues was similar to living tissues.
The net OD of the treated killed tissues was subtracted from the ODs of the test item treated viable tissues.
DYE BINDING METHOD
- Dye used in the dye-binding assay: MTT
- Incubation time: 3 hours
- Spectrophotometer: TECAN Infinite® M200 Pro Plate Reader.
- Wavelength: 570 nm
PREDICTION MODEL / DECISION CRITERIA
- The test substance is considered to be irritant to skin if the relative mean tissue viability of three individual tissues after 15 minutes of exposure to the test item and 42 hours of post incubation is ≤ 50% of the mean viability of the negative controls.
- The test substance is considered to be non-irritant to skin if the relative mean tissue viability of three individual tissues after 15 minutes of exposure to the test item and 42 hours of post incubation is > 50% of the mean viability of the negative controls.
SCORING SYSTEM:
- Cytotoxicity is expressed as the reduction of mitochondrial dehydrogenase activity measured by formazan production from MTT at the end of the treatment. Cell viability was calculated for each tissue as a percentage of the mean of the negative control tissues. Skin irritation is expressed as the remaining cell viability after exposure to the test item.
ACCEPTABILITY CRITERIA:
- The absolute mean OD570 (optical density at 570 nm) of the three tissues of the negative control should reasonably be within the laboratory historical control data range and the Standard Deviation value (SD) of the % viability should be ≤18.
- The mean relative tissue viability of the positive control should be ≤ 50% relative to the negative control and the Standard Deviation value (SD) of the % viability should be ≤18.
- The SD calculated from individual % tissue viabilities of the three identically treated replicates should be ≤18.
- The %NSCliving should be ≤ 30% relative to the negative control OD.
- The non-specific MTT reduction should be ≤ 30% relative to the negative control OD. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount applied: 11.64 - 15.98 mg
- The test item was applied directly to the tissues (moistened with 5 μL Milli-Q water)
NEGATIVE CONTROL
- Amount applied: 25 μL PBS
POSITIVE CONTROL
- Amount applied: 25 μL 5% SDS
- The positive control was respread after 7 minutes of contact time. - Duration of treatment / exposure:
- 15 ±0.5 minutes
- Duration of post-treatment incubation (if applicable):
- 42 hours and 3 hours with MTT
- Number of replicates:
- - 3 tissues for the test item
- 3 tissues for the positive and the negative controls each
- 3 killed tissues treated with test item and 3 killed untreated tissues - Irritation / corrosion parameter:
- % tissue viability
- Value:
- 15
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks:
- 15 ± 6.7%
- Remarks on result:
- other: SD: 5.6%
- Other effects / acceptance of results:
- - OTHER EFFECTS:
- Visible damage on test system: no
- Direct-MTT reduction: no
- Colour interference with MTT: no
DEMONSTRATION OF TECHNICAL PROFICIENCY: the mean tissue viability of the positive controls was 15%, showing that the test system functioned properly.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: yes, the absolute mean OD570 (optical density at 570 nm) of the three tissues of the negative control was within the laboratory historical control data range and the Standard Deviation value (SD) of the % viability was ≤ 18 (i.e., 5.3).
- Acceptance criteria met for positive control: yes, the mean relative tissue viability of the positive control was ≤ 50% relative to the negative control (i.e., 15%) and the Standard Deviation value (SD) of the % viability was ≤ 18 (i.e., 6.7)
- Acceptance criteria met for variability between replicate measurements: yes, the SD calculated from individual % tissue viabilities of the three identically treated was ≤ 18 (i.e., 5.6)
- The %NS MTT: -0.301
- Since the test item showed to be not corrosive to the skin in an earlier study, the test item is classified as Category 2 taken the results of both the corrosion and the irritation study into account. - Interpretation of results:
- Category 2 (irritant) based on GHS criteria
- Remarks:
- Category 2 according to Regulation (EC) 1272/2008
- Conclusions:
- An in vitro skin irritation study showed that Menadione was irritant to the skin (mean tissue viability of 15%) and should be classified as Category 2 according to GHS and according to Regulation (EC) 1272/2008.
- Endpoint:
- skin corrosion: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 11 July 2017 - 14 July 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 431 (In Vitro Skin Corrosion: Reconstructed Human Epidermis (RHE) Test Method)
- Version / remarks:
- 29 July 2016
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: EC Guideline No. 440/2008. Part B: Methods for the Determination of Toxicity and other health effects, Guideline B.40 BIS: "In Vitro Skin Corrosion: Human Skin Model Test". Official Journal of the European Union No. L142
- Version / remarks:
- 31 May 2008
- Deviations:
- no
- GLP compliance:
- yes
- Specific details on test material used for the study:
- - No correction factor for purity required.
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Cell source:
- skin obtained from plastic surgery from multiple donors
- Justification for test system used:
- Recommended test system in international guidelines (OECD and EC).
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: EpiDerm Skin Model
- Tissue batch number(s): 26490
- Surface: 0.6 cm^2
- On the day of receipt the tissues were kept on agarose and stored in the refrigerator.
- Test for color interference by the test item: 25 mg test item was added to 0.3 mL Milli-Q water and the mixture was incubated for approx. 1 hour at 37.0 ± 1.0°C in the dark. At the end of the exposure time the mixture was shaken and it was checked if a blue/purple color change was observed. A negative control (Milli-Q water) was tested concurrently.
- Test for reduction of MTT by the test item: 25 mg test item was added to 1mL MTT solution (1mg/mL in phosphate buffered saline. The mixture was incubated for approx. 1 hour at 37.0 ± 1.0°C. At the end of the exposure time it was checked if a blue/purple color change was observed or a blue/purple precipitate was observed. A negative control (Milli-Q water) was tested concurrently.
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: room temperature
- Temperature of post-treatment incubation: 36.8-37.5°C
REMOVAL OF TEST MATERIAL AND CONTROLS
-Volume and number of washing steps: after exposure and after incubation tissues were washed with phosphate buffered saline (once)
- Observable damage in the tissue due to washing: no
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 1 mg/mL
- Incubation time: 3 hours
- Spectrophotometer: TECAN Infinite® M200 Pro Plate Reader
- Wavelength: 570 nm
NUMBER OF REPLICATE TISSUES: 2 per exposure duration + 2 for the negative control and the positive control each
NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION: 1 experiment with 3 independent OD570 measurements per replicate.
ACCEPTABILITY CRITERIA
- The absolute mean OD570 of the two tissues of the negative control should reasonably be within the laboratory historical control data range (≥0.8 and ≤2.8).
- The mean relative tissue viability following 1-hour exposure to the positive control should be <15 %.
- In the range 20 - 100% viability, the Coefficient of Variation (CV) between tissue replicates should be ≤ 30%.
DECISION CRITERIA
A test item is considered corrosive in the in vitro skin corrosion test if:
- The relative mean tissue viability obtained after 3-minute treatment compared to the negative control tissues is decreased below 50%.
- In addition, a test item considered non-corrosive (viability ≥ 50%) after the 3-minute treatment is considered corrosive if the relative tissue viability after 1-hour treatment with the test item is decreased below 15%.
A test item is considered non-corrosive in the in vitro skin corrosion test if:
- The relative mean tissue viability obtained after the 3-minute treatment compared to the negative control tissues is not decreased below 50%.
- In addition, the relative tissue viability after the 1-hour treatment is not decreased below 15%. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount applied: 25.1 - 36.3 mg
- The test item was applied directly on top of the skin tissues (pre-wetted with 25 μl Milli-Q water), spread to match the size of the tissue.
NEGATIVE CONTROL
- Amount applied: 50 μL
POSITIVE CONTROL
- Amount applied: 50 μL (8N KOH) - Duration of treatment / exposure:
- 3 minute and 1 hour
- Duration of post-treatment incubation (if applicable):
- 3 hours in MTT medium
- Number of replicates:
- 2 tissues per test item per exposure time (4 tissues in total)
- Irritation / corrosion parameter:
- % tissue viability
- Remarks:
- mean of 2 replicates
- Run / experiment:
- 3-minute exposure
- Value:
- 100
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks:
- mean tissue viability: 6.5%
- Irritation / corrosion parameter:
- % tissue viability
- Remarks:
- mean of 2 replicates
- Run / experiment:
- 1-hour exposure
- Value:
- 81
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks:
- mean tissue viability: 11%
- Other effects / acceptance of results:
- - OTHER EFFECTS:
- Visible damage on test system: no
- Direct-MTT reduction: no
- Colour interference with MTT: no
DEMONSTRATION OF TECHNICAL PROFICIENCY: the results of the positive control data were within the historical data range and thereby showing the test system functioned properly.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: yes, the absolute mean OD570 of the two tissues of the negative control was within the laboratory historical control data range (i.e., 1.718 for the 3-minute exposure period and 1.490 for the 1-hour exposure period).
- Acceptance criteria met for positive control: yes, the mean relative tissue viability following 1-hour exposure to the positive control was <15 % (i.e., 11%).
- Acceptance criteria met for variability between replicate measurements: yes, the Coefficient of Variation (CV) between tissue replicates was ≤ 30% (i.e., ≤ 22%) - Interpretation of results:
- GHS criteria not met
- Remarks:
- Not classified according to Regulation (EC) 1272/2008.
- Conclusions:
- In the in vitro skin corrosion test, Menadione was found to be not corrosive to the skin (mean tissue viability of 100% and 81% after a 3-minute and a 1-hour exposure period, respectively). The test item is not classified according to GHS and according to Regulation (EC) 1272/2008.
Referenceopen allclose all
Table 2 Individual OD measurements at 570 nm
|
A (OD570) |
B (OD570) |
C (OD570) |
Negative control OD570measurement 1 OD570measurement 2 |
0.9943 1.0347 |
0.9044 0.9579 |
0.9697 1.0724 |
Menadione on viable tissue OD570measurement 1 OD570measurement 2 |
0.1342 0.1460 |
0.2585 0.2523 |
0.1540 0.1527 |
Menadione on killed tissue OD570measurement 1 OD570measurement 2 |
0.1322 0.1413 |
0.1463 0.1445 |
0.1597 0.1606 |
Non treated killed tissue OD570measurement 1 OD570measurement 2 |
0.1562 0.1625 |
0.1454 0.1623 |
0.1377 0.1376 |
Positive control OD570measurement 1 OD570measurement 2 |
0.2312 0.2329 |
0.2012 0.2064 |
0.1277 0.1298 |
OD = Optical density
Triplicate exposures are indicated by A, B and C.
Table 3 Historical data
|
Negative control (absorption; OD570) |
Positive control (absorption; OD570) |
Positive control (viability; %) |
Range |
0.676 – 1.336 |
0.036 – 0.549 |
2.85 – 45.43 |
Mean |
1.01 |
0.16 |
15.74 |
SD |
0.16 |
0.10 |
9.22 |
n |
155 |
154 |
163 |
SD = Standard deviation; n = Number of observations
The above mentioned historical control data range of the controls were obtained by collecting all data over the period of November 2013 to November 2016.
Table 1 Individual OD measurements at 570 nm
|
3-minute application (OD570) A B |
1-hour application (OD570) A B |
||
Negative control OD570measurement 1 OD570measurement 2 OD570measurement 3 |
|
|
||
1.6989 |
1.7387 |
1.2470 |
1.6792 |
|
1.8178 |
1.7863 |
1.4028 |
1.7471 |
|
1.7492 |
1.7720 |
1.3922 |
1.7311 |
|
Menadione OD570measurement 1 OD570measurement 2 OD570measurement 3 |
|
|
||
1.7633 |
1.7594 |
1.1644 |
1.2748 |
|
1.9101 |
1.6178 |
1.2889 |
1.2677 |
|
1.8572 |
1.6556 |
1.2826 |
1.2631 |
|
Positive control OD570measurement 1 OD570measurement 2 OD570measurement 3 |
|
|
||
0.1498 |
0.1506 |
0.1906 |
0.2170 |
|
0.1630 |
0.1508 |
0.2064 |
0.2273 |
|
0.1629 |
0.1516 |
0.2039 |
0.2269 |
OD = Optical density
Duplicate exposures are indicated by A and B.
Table 2 Historical control data
|
Negative control |
Positive control |
Positive control |
|||
|
3-minute treatment (OD570) |
1-hour treatment (OD570) |
3-minute treatment (OD570) |
1-hour treatment (OD570) |
3-minute treatment (% viability) |
1-hour treatment (% viability) |
Range |
1.324 – 2.615 |
1.361 – 2.352 |
0.0172 – 0.56 |
0.046 – 0.339 |
6 – 25 |
3 – 13 |
Mean |
1.84 |
1.85 |
0.19 |
0.14 |
11.03 |
7.45 |
SD |
0.26 |
0.22 |
0.09 |
0.06 |
4.39 |
2.51 |
n |
81 |
83 |
80 |
77 |
38 |
38 |
SD = Standard deviation; n = Number of observations
The above mentioned historical control data range of the controls were obtained by collecting all data over the period of November 2013 to November 2016.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 02 August 2017 - 04 August 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- 28 July 2015
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- dd 03 November 2015
- Specific details on test material used for the study:
- No correction for purity required
- Species:
- human
- Details on test animals or tissues and environmental conditions:
- TEST SYSTEM:
The EpiOcular tissue construct is a nonkeratinized epithelium prepared from normal human keratinocytes. It models the cornea epithelium with progressively stratified, but not cornified cells. A cell suspension is seeded into the insert in specialized medium. After an initial period of submerged culture, the medium is removed from the top of the tissue so that the epithelial surface is in direct contact with the air. This allows the test material to be directly applied to the epithelial surface in a fashion similar to how the corneal epithelium would be exposed in vivo.
- Justification: In the interest of sound science and animal welfare, a sequential testing strategy is recommended to minimize the need of in vivo testing. One of the validated in vitro eye irritation tests is the EpiOcular test, which is recommended in international guidelines and scientific publications (e.g. OECD). - Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount applied: 55.7 - 65.3 mg
- The test material was directly applied to the tissues which were pre-wetted with 20 μL of Ca2+Mg2+-Free-DPBS.
- Positive control: 50 μl Methyl Acetate
- Negative control: 50 μl Milli-Q water - Duration of treatment / exposure:
- 6 hours ± 15 minutes
- Duration of post- treatment incubation (in vitro):
- Post-soak: 25 ± 2 minutes; incubation after the post-soak: 18 hours ± 15 minutes
- Number of animals or in vitro replicates:
- 2 tissues per test item and 2 tissues for the negative and the positive control each.
- Details on study design:
- - Details of the test procedure used:
- RhCE tissue construct used, including batch number: EpiOcular™ (OCL-200-EIT MatTek Corporation, Lot: 23491)
- Duration and temperature:
* exposure: 6 hours ± 15 minutes at 37.0 ± 1.0°C
After the exposure period, the tissues were thoroughly rinsed with Ca2+Mg2+-free DPBS (brought to room temperature) to remove residual test item.
* post-soak immersion: 25 ± 2 minutes at room temperature in assay medium
* incubation: 18 hours ± 15 minutes at 37°C in assay medium + 180 minutes with MTT
- The test item was checked for possible color interference and possible direct MTT reduction before the study was started.
- Cell viability measurements:
After incubation, the tissues were incubated with 0.3 ml MTT-medium (1.0 mg/ml) for 180 ± 10 minutes at 37°C. After incubation with MTT-medium the tissues were transferred to a 6-well plate containing 2 ml isopropanol. Formazan was extracted with 2 mL isopropanol for 2 - 3 hours at room temperature with gentle shaking. The amount of extracted formazan was determined spectrophotometrically at 570 nm in duplicate with the TECAN Infinite® M200 Pro Plate Reader. Cell viability was calculated for each tissue as a percentage of the mean of the negative control tissues. Eye hazard potential of the test item was classified according to remaining
cell viability following exposure of the test item.
- Evaluation criteria:
* The test chemical is identified as not requiring classification and labelling according to UN GHS (No Category) if the mean percent tissue viability after exposure and post-exposure incubation is more than (>) 60%. In this case no further testing in other test methods is required.
* The test chemical is identified as potentially requiring classification and labelling according to UN GHS (Category 2 or Category 1) if the mean percent tissue viability after exposure and post-exposure incubation is less than or equal (≤) to 60%.
- Acceptability criteria:
* The absolute mean OD570 of the two tissues of the negative control should reasonably be > 0.8 and < 2.5.
* The mean relative tissue viability of the positive control should be <50% relative to the negative control.
* The difference between the % tissue viabilities of the two identically treated replicates should be <20%. - Irritation parameter:
- other: mean cell viability (percentage of negative control)
- Value:
- 7.2
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks:
- 29%
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: no
DEMONSTRATION OF TECHNICAL PROFICIENCY: see 'any other information on results' for historical data. Results for the positive control were within the historical data range and therefore showing that the test system was functioning properly.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: yes, the absolute mean OD570 of the two tissues of the negative control was between >0.8 and <2.5 (i.e., 1.734)
- Acceptance criteria met for positive control: yes, the mean relative tissue viability of the positive control was <50% (i.e., 29%)
- The difference between the % tissue viabilities of the two identically treated replicates was <20% (i.e., 3.4, 0.71 and 0.10 for the negative control, the treatment group and the positive control respectively)
- Based on the results, the test substance is considered to be potentially irritating to the eyes and is classified as Category 1 or 2 according to the CLP regulation (Regulation (EC) No. 1272/2008). - Interpretation of results:
- other: Category 1 or Category 2 according to Regulation (EC) 1272/2008.
- Conclusions:
- Based on the EpiOcular test, resulting in a mean cell viability of 7.2% compared to the negative control, Menadione is potentially irritant or corrosive to the eyes. The test item should be classified as Category 1 or Category 2 (based on the results no differentiation between categories can be made).
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 19 June 2017 - 20 June 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying Ocular Corrosives and Severe Irritants)
- Version / remarks:
- 26 July 2013
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- dd. 3 November 2015
- Specific details on test material used for the study:
- No correction for purity required
- Species:
- cattle
- Details on test animals or tissues and environmental conditions:
- SOURCE OF COLLECTED EYES
- Source: young cattle, obtained from the slaughterhouse Vitelco, 's-Hertogenbosch, The Netherlands.
- Storage, temperature and transport conditions of ocular tissue: eyes were excised by a slaughterhouse employee as soon as possible after slaughter. Subsequently, eyes were collected an transported in physiological saline in a suitable container under cooled conditions.
- The eyes were checked for unacceptable defects and those exhibiting defects were discarded.
- Isolated corneas were stored in a petri dish with cMEM containing 1% (v/v) L-glutamine and 1% (v/v) Fetal Bovine Serum. - Vehicle:
- unchanged (no vehicle)
- Remarks:
- Since no workable suspension of the test substance in physiological saline could be obtained, the test item was used as delivered by the sponsor and added pure on top of the corneas.
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount applied: 300.13 - 320.69 (complete coverage of the cornea)
NEGATIVE CONTROL: Physiological saline
- Amount applied: 750 µL
POSITIVE CONTROL: Imidazole 20% (w/w)
- Amount applied: 750 µL - Duration of treatment / exposure:
- 240 ± 10 minutes
- Duration of post- treatment incubation (in vitro):
- 90 ±5 minutes in sodium-fluorescein for permeability determinations
- Number of animals or in vitro replicates:
- 3 for the negative control, the positive control and the treatment group each.
- Details on study design:
- TREATMENT METHOD: The medium from the anterior compartment was removed and 750 µL of the negative control and the positive control were introduced onto the epithelium of the cornea. The test substance was weighed in a bottle and applied directly on the corneas in such a way that the cornea was completely covered (300.13 to 320.69 mg). The holders were slightly rotated, with the corneas maintained in a horizontal position, to ensure uniform distribution of the control or the test item over the entire cornea. Corneas were incubated in a horizontal position for 240 ± 10 minutes at 32±1 °C.
REMOVAL OF TEST SUBSTANCE
- Number of washing steps after exposure period: After the incubation the solutions were removed and the epithelium was washed at least three times with MEM with phenol red (Earle’s Minimum Essential Medium, Life Technologies).
- POST-EXPOSURE INCUBATION: 90 ±5 minutes in sodium-fluorescein for permeability determinations
METHODS FOR MEASURED ENDPOINTS:
- Corneal opacity: opacity meter (OP-KIT)
- Corneal permeability: passage of sodium fluorescein dye measured with the aid of a microtiter plate reader (TECAN Infinite® M200 Pro Plate Reader, OD490). OD490 values of less than 1.500 were used in the permeability calculation.
- Other: possible pH effects of the test substance on the corneas were recorded. Each cornea was inspected visually for dissimilar opacity patterns.
SCORING SYSTEM: In Vitro Irritancy Score (IVIS)
DECISION CRITERIA (see table 1):
A test substance that induces an IVIS ≤ 3 is not classified for eye irritancy (UN GHS: no category);
A test substance that induces IVIS >55 is defined as a corrosive or severe irritant (UN GHS: category 1);
For a test substance that induces an IVIS >3 and ≤55, no prediction on irritant potency can be made.
ACCEPTABILITY CRITERIA:
The assay is considered acceptable if:
- The positive control gives an in vitro irritancy score that falls within two standard deviations of the current historical mean.
- The negative control responses should result in opacity and permeability values that are less than the upper limits of the laboratory historical range. - Irritation parameter:
- in vitro irritation score
- Run / experiment:
- Mean of 3 replicates
- Value:
- 13
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- IVIS: 2.7-4.3
- Positive controls validity:
- valid
- Remarks:
- IVIS: 131.7-156.4
- Other effects / acceptance of results:
- - The corneas treated with the test substance showed opacity values between 4.7 and 10.3.
- Permeability values were ranging from 0.018 to 0.861.
- IVIS scores were 7.0, 10.5 and 20.0 (n=3). Since the IVIS scores were > 3 and ≤ 55, no prediction on irritant potency can be made.
OTHER EFFECTS:
- A pH effect of the test item was observed on the rinsing medium, the corneas were rinsed until no colour change of the medium was observed.
- The corneas were turbid yellow after the 240 minutes of treatment with the test substance.
- In the first experiment, one of the negative control eyes was slightly turbid. In the second experiment two of the negative control eye were slightly turbid. This had no effect on the validity of the experiment since the opacity and permeability values were within the historical data range.
ACCEPTANCE OF RESULTS (see table 2 for historical data):
- Acceptance criteria met for negative control: yes, responses for opacity and permeability were less than the upper limits of the historical data range (IVIS ranging from 2.7 to 4.3).
- Acceptance criteria met for positive control: yes, results were within two standard deviations of the historical mean (136.63, SD 27.51 and 2SD 55.02). Corneas were turbid after 240 minutes of treatment. - Interpretation of results:
- study cannot be used for classification
- Conclusions:
- Based on the outcome of a Bovine Corneal Opacity and Permeability test (BCOP) performed according to OECD guideline 437 and GLP principles, no prediction can be made for classification for eye irritation of Menadione since the IVIS was > 3 and ≤ 55 (mean IVIS of 13).
Referenceopen allclose all
Table 1 Historical data
|
Negative control (absorption; OD570) |
Positive control (absorption; OD570) |
Positive control (viability; %) |
Range |
1.228 – 2.090 |
0.320 – 0.535 |
17.80 – 34.18 |
Mean |
1.53 |
0.42 |
27.55 |
SD |
0.23 |
0.07 |
5.31 |
n |
12 |
12 |
12 |
SD = Standard deviation; n = Number of observations
The above mentioned historical control data range of the controls were obtained by collecting all data over the period of January 2013 to May 2017.
Table 2 Individual OD measurements at 570 Nm
|
A (OD570) |
B (OD570) |
Negative control OD570 measurement 1 OD570 measurement 2 |
1.7689 1.6991 |
1.8253 1.8100 |
Menadione OD570 measurement 1 OD570 measurement 2 |
0.1767 0.1732 |
0.1592 0.1561 |
Positive control OD570 measurement 1 OD570 measurement 2 |
0.5405 0.5345 |
0.5356 0.5343 |
OD = Optical density
Duplicate exposures are indicated by A and B.
Table 2 Historical Control Data for the BCOP Studies
|
Negative control |
Positive control |
||
|
Opacity |
Permeability |
In vitro Irritancy Score |
In vitro Irritancy Score |
Range |
-5.4 – 5.2 |
-0.010 – 0.205 |
-5.3 – 5.3 |
86.5 - 211.4 |
Mean |
0.33 |
0.02 |
0.53 |
136.63 |
SD |
1.77 |
0.02 |
1.81 |
27.51 |
n |
110 |
110 |
113 |
111 |
SD = Standard deviation
n = Number of observations
The above mentioned historical control data range of the controls were obtained by collecting all data over the period of May 2014 to May 2017.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
An in vitro skin irritation study showed that Menadione was irritant to the skin (mean tissue viability of 15%) and should be classified as Category 2 according to GHS and according to Regulation (EC) 1272/2008.
In the in vitro skin corrosion test, Menadione was found to be not corrosive to the skin (mean tissue viability of 100% and 81% after a 3-minute and a 1-hour exposure period, respectively). The test item is not classified according to GHS and according to Regulation (EC) 1272/2008.
Based on the EpiOcular test, resulting in a mean cell viability of 7.2% compared to the negative control, Menadione is potentially irritant or corrosive to the eyes. The test item should be classified as Category 1 or Category 2 (based on the results no differentiation between categories can be made).
Based on the outcome of a Bovine Corneal Opacity and Permeability test (BCOP) performed according to OECD guideline 437 and GLP principles, no prediction can be made for classification for eye irritation of Menadione since the IVIS was > 3 and ≤ 55 (mean IVIS of 13).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.